- $3.70bn
- $4.64bn
- $5.33bn
- 92
- 81
- 96
- 99
2019 April 30th | 2020 April 30th | 2021 April 30th | 2022 April 30th | 2023 April 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 3,116 | 3,241 | 3,299 | 4,635 | 5,329 |
Cost of Revenue | |||||
Gross Profit | 1,004 | 1,063 | 1,063 | 1,488 | 1,726 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 2,969 | 3,128 | 3,106 | 4,216 | 4,824 |
Operating Profit | 147 | 114 | 192 | 419 | 505 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 70 | 46.3 | 137 | 365 | 448 |
Provision for Income Taxes | |||||
Net Income After Taxes | 55.9 | 23.4 | 106 | 273 | 333 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 56 | 23.4 | 106 | 273 | 333 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 54.6 | 23.3 | 106 | 273 | 333 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.56 | 1.32 | 2.49 | 6.29 | 7.87 |